Pier 1 Imports, Inc. Adopts Short-Term Shareholder Rights Protection Agreement
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Jefferies Raises price Target on Pier 1 Imports (PIR) Following 2Q Report
September 29, 2016 8:49 AM EDTJefferies reiterated a Hold rating on Pier 1 Imports (NYSE: PIR), and raised the price target to $4.50 (from $4.25), following the company's 2Q earnings report. Merchandise margins were in line with guidance on a more balanced promotional posture and improved distribution center efficiency.
Analyst... More
Alden 'Disappointed' in Pier 1 Imports' (PIR) Adoption of 10% Poison Pill
September 28, 2016 3:47 PM EDTAlden Global Capital LLC , the largest active shareholder of Pier 1 Imports, Inc. (NYSE: PIR), with ownership of approximately 9.5% of Pier 1's outstanding shares, issued a statement today in response to Pier 1's post-market announcement on September 27, 2016 that it has adopted a "poison pill" rights plan (the "Poison Pill") with a 10% ownership limitation. Alden is severely disappointed that Pier 1 has resorted to this highly questionable form of entrenchment rather than engage constructively with one of its largest shareholders.
Heath Freeman, President of Alden, stated, "We were incredibly surprised and disappointed to learn... More
